<?xml version="1.0" encoding="utf-8"?>
	<collection>
		
	
		<source>SourceData</source>
		
	
		<date>2019-04-19</date>
		
	
		<key>sourcedata.key</key>
		
	
		<document>
			
		
			<id>5167135 Figure_2-A</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 2-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. SHOXprotein representation and luciferase assay. The variants found in SHOX are indicated in red. Luciferase assays to test the impact of SHOX mutations on its transcriptional activity were performed on FGFR3 promoter in U2OS cells (n = 4). Experiments were performed in triplicates. pcDNA4-TO empty vector was used as control. R153L represents a mutation known to affect SHOXprotein activity and was used as positive control (Schneider et al., 2005). Homeodomain, DNA binding domain; Src Homology 3 domain; OAR, OtpAristalessRax domain. RLU, Relative Light Units.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:OtpAristalessRax</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="16" offset="516"/>
					
				
					<text>OtpAristalessRax</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="10" offset="34"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:Luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="10" offset="101"/>
					
				
					<text>Luciferase</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_2-B</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 2-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_2-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. CYP26C1protein representation and luciferase assay. Variants found in CYP26C1 are indicated in green. Cignal-RARE system luciferase assays to test the impact of CYP26C1 variants on its RA degradation activity were performed in U2OS cells treated with 250 nM all-trans retinoic acid (ATRA) for 24 hours (n = 4). Experiments were performed in triplicates.pIRES2-EGFP empty vector was used as control. The residue C459 represents the Iron binding residue (Q6VOL0, UniProtKB) and was mutated to Ala and used as a positive control. TM, Transmembrane helix; P450, cytochrome p450 domain. RLU, Relative Light Units.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="10" offset="37"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="10" offset="124"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:cytochrome</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="10" offset="561"/>
					
				
					<text>cytochrome</text>
					
			
				</annotation>
				
			
				<annotation id="4">
					
				
					<infon key="type">protein:EGFP</infon>
					
				
					<infon key="sourcedata_figure_annot_id">4</infon>
					
				
					<infon key="sourcedata_article_annot_id">4</infon>
					
				
					<location length="4" offset="363"/>
					
				
					<text>EGFP</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_3-A-1</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 3-A-1</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-A-1</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. Left panel, RT-PCR showing the expression of CYP26C1 mRNA in human primary chondrocytes. SOX9 was used as chondrocyte marker.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_3-A-2</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 3-A-2</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-A-2</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A. Right panel, western blot showing the expression of CYP26C1 in human primary chondrocytes on protein level. Overexpression of CYP26C1 in U2OS cells was carried out to compare protein sizes. +, cDNA; -, water; M, marker; HPC, human primary chondrocytes.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_3-B</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 3-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>B. Relative expression of SHOX mRNA normalized to the reference genes SDHA and HPRT in human primary chondrocytes treated with ATRA 100 nM for 6h (n = 5). One outlier with high relative expression (2.3 fold) was excluded from ATRA 100 nM treatment (two-sided Grubb's test, Z value 2.34, p-value &amp;lt; 0.05).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_3-C</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 3-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_3-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>C. SHOX promoter was cloned in pGL3basic for luciferase reporter experiments as previously described (Verdin et al, 2015). In silico analysis of SHOX promoter identified three putative RXRa binding sites which were mutated to test their direct effect on SHOX expression upon treatment with ATRA 250 nM in U2OS cells (n = 4). Experiments were performed in triplicates. RLU, Relative Light Units.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="10" offset="45"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:SHOX</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="4" offset="3"/>
					
				
					<text>SHOX</text>
					
			
				</annotation>
				
			
				<annotation id="3">
					
				
					<infon key="type">protein:SHOX</infon>
					
				
					<infon key="sourcedata_figure_annot_id">3</infon>
					
				
					<infon key="sourcedata_article_annot_id">3</infon>
					
				
					<location length="4" offset="145"/>
					
				
					<text>SHOX</text>
					
			
				</annotation>
				
			
				<annotation id="4">
					
				
					<infon key="type">protein:SHOX</infon>
					
				
					<infon key="sourcedata_figure_annot_id">4</infon>
					
				
					<infon key="sourcedata_article_annot_id">4</infon>
					
				
					<location length="4" offset="254"/>
					
				
					<text>SHOX</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_4-A-B</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 4-A-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-C. Wild type embryos injected with control MO or with shox MO. (A) Lateral views of the embryos at 55 hours post fertilization (hpf). (B) Dorsal view and magnification on the lateral view of the embryos. Dotted line, pectoral fins. shox morphants show smaller fins compared to controls (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_4-C</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 4-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-C. Wild type embryos injected with control MO or with shox MO. C. Expression of col2a1 at 55 hpf was examined by in situ hybridization in wild type embryos injected with control MO and with shox MO. Arrow and dotted line indicate the pectoral fin.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_4-D</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 4-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_4-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-C. Wild type embryos injected with control MO or with shox MO. D. Pectoral fin area was measured by imageJ (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-A-B</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-A-B</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-D. Wild type embryos injected with control MO or with cyp26c1 MO. (A) Lateral views of the embryos at 55 hours post fertilization (hpf). (B) Dorsal view and magnification on the lateral view of the embryos. Dotted line, pectoral fins; *, otic vesicle. cyp26c1 morphants show smaller fins compared to controls (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-C-D</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-C-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-C-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-D. Wild type embryos injected with control MO or with cyp26c1 MO. (C, D) Expression of col2a1(C) and shox (D) at 55 hpf was examined by in situ hybridization in embryos injected with control MO or with cyp26c1 MO. (C) Dorsal view and magnification on the pectoral fins of col2a1expression. Arrow and dotted line indicate the pectoral fin. (D) Dorsal view and magnification on the pectoral fins of shox expression. Arrow and dotted line indicate the pectoral fin.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-E</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>E. Pectoral fin area was measured by imageJ (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-F</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-F</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-F</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>F. Cignal-RARE system luciferase assay testing cyp26c1 MO on RA acid levels in zebrafishembryos (n = 5 replicates). Embryos were separated in groups of 20-30 and luciferase assayed. RLU, Relative Light Units.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="10" offset="22"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
			
				<annotation id="2">
					
				
					<infon key="type">protein:luciferase</infon>
					
				
					<infon key="sourcedata_figure_annot_id">2</infon>
					
				
					<infon key="sourcedata_article_annot_id">2</infon>
					
				
					<location length="10" offset="162"/>
					
				
					<text>luciferase</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-G</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-G</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-G</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>G. Relative shox mRNA expression normalized to reference genes eef1a and b-actin in zebrafish embryos injected with control MO or cyp26c1 MO (n = 4). RNA was extracted from 10-15 injected embryos at 55 hours post fertilization.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:actin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="75"/>
					
				
					<text>actin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_5-H</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 5-H</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_5-H</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>H. Relative shox mRNA expression normalized to reference genes eef1a and b-actin in zebrafish embryos treated with 100 nM ATRA (n = 4). Embryos were collected at 24 hpf and treated with mock control or ATRA. RNA was extracted from 10-15 embryos after 6 hours treatment.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:actin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="75"/>
					
				
					<text>actin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_6-A</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 6-A</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-A</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-C. Wild type embryos injected with control MO, subphenotypic doses of shox MO, cyp26c1 MO or a combination of shox + cyp26c1 MOs. (A) Dorsal views of the embryos at 55 hours post fertilization (hpf). Dotted line, pectoral fins. shox + cyp26c1 double morphants show smaller fins compared to control and single MOs (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_6-B-C</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 6-B-C</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>A-C. Wild type embryos injected with control MO, subphenotypic doses of shox MO, cyp26c1 MO or a combination of shox + cyp26c1 MOs. (B, C) Dorsal view and magnification on the pectoral fins of col2a1 expression at 55 hpf. Arrow and dotted line indicate the pectoral fin.</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_6-D</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 6-D</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-D</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>D. Pectoral fins area was measured by imageJ (n = 30 embryos).</text>
				
		
			</passage>
			
	
		</document>
		
	
		<document>
			
		
			<id>5167135 Figure_6-E</id>
			
		
			<infon key="sourcedata_document">2442</infon>
			
		
			<infon key="doi">10.15252/emmm.201606623</infon>
			
		
			<infon key="pmc_id">5167135</infon>
			
		
			<infon key="figure">Figure 6-E</infon>
			
		
			<infon key="sourcedata_figure_dir">Figure_6-E</infon>
			
		
			<passage>
				
			
				<offset>0</offset>
				
			
				<text>E. Relative expression of shox mRNA normalized to reference genes eef1a and b-actin in zebrafish embryos injected with control MO, shox MO, cyp26c1 MO, or shox + cyp26c1 MOs (n = 4). RNA was extracted from 10-15 injected embryos at 55 hours post fertilization.</text>
				
			
				<annotation id="1">
					
				
					<infon key="type">protein:actin</infon>
					
				
					<infon key="sourcedata_figure_annot_id">1</infon>
					
				
					<infon key="sourcedata_article_annot_id">1</infon>
					
				
					<location length="5" offset="78"/>
					
				
					<text>actin</text>
					
			
				</annotation>
				
		
			</passage>
			
	
		</document>
		

	</collection>
